InsidersTradesSigma
우정바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 우정바이오 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 우정바이오 has recorded 71 reports. Market capitalisation: €41.7bn. The latest transaction was reported on 4 June 2026 (Purchase). Among the most active insiders: 수성자산운용. The full history is openly available.
71
Insider Decl.
0
Thresholds
€12,441
15 ops.
Buy Volume
·
38 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,037 of 25,451 companies
21.5
score / 100
Value22
Quality21
FCF yld-2.1%
Earn yld-13%
EV/EBITDA·
ROE-15%
Gross mgn27%
Net mgn-15%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 June 2026
Declarations71 total
950,000 sharesKRXDART:20241213000293
Ideal exit: 2 Sept 2025 (T+270)
25 of 71 declarations